Vasomedical Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc.

VASO 0.170

0.0%

3:16 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Doug DuBois who wrote (539)	9/13/1997 8:55:00 AM
From: Michael Yang	of 1605

Thanks for leading me to the site. It is doubtful that patients can make big differences in pursuing the reimbursement by themself without endorsement from the medical community. Hence the importance of the multicenter trial is not just a "milestone" in the EECP per se but also a step towards general preventive medicine which should be pursued by the insurance companies. It should be realized that build-up of collateral blood flow can reduce costs involved in "open chest" surgery which will be obsolete in many cases. It is simple math to compare invasive to non invasive cost. Back to the numbers. Sorry to those TA people. I believe more in fundamentals.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next